Rare Disease Advisor/LinkedIn
Sep 5, 2025, 10:59
New Study Featured by Rare Disease Advisor Reveals Quality-of-Life Challenges in Hemophilia
Rare Disease Advisor posted on LinkedIn:
”Regardless of treatment regimen or disease severity, patients with Hemophilia often shoulder a significant treatment and disease burden that adversely impacts quality of life, according to a study published in Haemophilia (World Federation of Hemophilia / Fédération mondiale de l’hémophilie).”
Read more here.
Stay updated with Hemostasis Today.
-
May 7, 2026, 17:56The Latest Clinical Data Shaping The Evolving Landscape of Hemophilia Treatment – EAHAD
-
May 7, 2026, 17:31Talha Badar: New Classical Hematology Chapter on Bleeding and Thrombosis
-
May 7, 2026, 17:26Maria Τektonidou: Gene Network Analysis Identifies STAT1 in Thrombotic APS
-
May 7, 2026, 17:23Sonu Bhaskar: Inflammatory Biomarkers in Acute Cerebral Venous Sinus Thrombosis
-
May 7, 2026, 16:53Patricio S. Espinosa: Anticoagulation Is Not an Absolute Contraindication to Amyloid Therapy
-
May 7, 2026, 16:34Arun V J: Give Blood and Be the Hero You Always Wanted to Be
-
May 7, 2026, 16:15August Bones: When Would You Consider Placing an Inferior Vena Cava Filter After a Pulmonary Embolism?
-
May 7, 2026, 15:58Stop Asking Doctors to Do More – Reimagining the Care Team – The US Oncology
-
May 7, 2026, 15:42Chokri Ben Lamine: CVC-Associated UE-DVT and Catheter Removal